ESMO 2025 Review: Bring me the horizon
From these sessions, CRA’s Aaron Everitt highlighted that while there are still relevant data releases and findings on existing immune checkpoint inhibitors,...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Mr. Aaron Everitt is a principal in the Life Sciences Practice of CRA. He has over five years of consulting experience in Pricing & Market Access, across the EU and US, with experience in LATAM, APAC and MEA. Dr. Everitt has a PhD background in immunology and virology.
